🟢 ANI Pharmaceuticals is trading 5% up in pre-market

ANI Pharmaceuticals is trading at $76.04, up 5.34% versus the October 2 close; no fresh October 5 catalyst was identified.

• The latest company announcement was September 30: Phase 4 eye-implant data will be presented at the October 2026 American Academy of Ophthalmology meeting.
• Major U.S. indices were little changed and mixed in the supplied pre-market context, so broad-market sentiment does not clearly explain the move. Trading volume was not available in the provided data.